VivoSim Labs, Inc. (formerly Organovo) is a pharmaceutical and biotechnology services company providing drug testing in 3D human tissue models of liver and intestine. The company offers liver toxicology predictive screening (NAMkind Human Liver Tissue) and intestinal side effect profiling services to pharmaceutical and biotech clients. Its platform demonstrated 87.5% sensitivity and 100% specificity for liver toxicity prediction. The company sold its FXR314 drug program to Eli Lilly in March 2025 for up to $60 million.
expected 2026-11-20
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-14 | 2026-03-31 | 0001193125-26-303316 | EDGAR | 63K words |
| 2025-06-05 | 2025-03-31 | 0000950170-25-082312 | EDGAR | 50K words |
| 2024-05-31 | 2024-03-31 | 0000950170-24-067301 | EDGAR | 48K words |
| 2023-07-14 | 2023-03-31 | 0000950170-23-032889 | EDGAR | 31K words |
| 2022-06-10 | 2022-03-31 | 0001564590-22-022994 | EDGAR | 41K words |
| 2021-06-15 | 2021-03-31 | 0001564590-21-032980 | EDGAR | 47K words |
| 2020-05-28 | 2020-03-31 | 0001564590-20-027310 | EDGAR | 46K words |
| 2019-06-03 | 2019-03-31 | 0001564590-19-021444 | EDGAR | 50K words |
| 2018-05-31 | 2018-03-31 | 0001564590-18-014814 | EDGAR | 50K words |
| 2017-06-07 | 2017-03-31 | 0001564590-17-012240 | EDGAR | 49K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-12 | 2026-09-30 | 0001193125-26-458330 | EDGAR | 45K words |
| 2026-08-12 | 2026-06-30 | 0001193125-26-346820 | EDGAR | 38K words |
| 2026-02-11 | 2025-12-31 | 0001193125-26-046520 | EDGAR | 40K words |
| 2025-11-06 | 2025-09-30 | 0001193125-25-269483 | EDGAR | 40K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107284 | EDGAR | 36K words |
| 2025-02-19 | 2024-12-31 | 0000950170-25-022778 | EDGAR | 42K words |
| 2024-11-08 | 2024-09-30 | 0000950170-24-124044 | EDGAR | 41K words |
| 2024-08-05 | 2024-06-30 | 0000950170-24-090726 | EDGAR | 36K words |
| 2024-02-08 | 2023-12-31 | 0000950170-24-012754 | EDGAR | 36K words |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062228 | EDGAR | 35K words |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041307 | EDGAR | 31K words |
| 2023-02-09 | 2022-12-31 | 0000950170-23-002327 | EDGAR | 34K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-10-16 | 0001193125-26-424061 | EDGAR | 2K words |
| 2026-10-06 | 0001193125-26-415542 | EDGAR | 11K words |
| 2026-08-21 | 0001193125-26-361085 | EDGAR | 1K words |
| 2026-08-06 | 0001193125-26-336844 | EDGAR | 1K words |
| 2026-07-30 | 0001193125-26-326139 | EDGAR | 1K words |
| 2026-07-24 | 0001213900-26-081377 | EDGAR | 1K words |
| 2026-07-17 | 0001193125-26-306849 | EDGAR | 1K words |
| 2026-04-03 | 0001193125-26-142106 | EDGAR | 3K words |
| 2025-12-18 | 0001193125-25-324794 | EDGAR | 1K words |
| 2025-08-14 | 0000950170-25-108447 | EDGAR | 1K words |
308 total filings indexed. 276 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001497253 |
| Ticker | VIVS |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Headquarters | San Diego, CA |
| Website | https://www.organovo.com |
| Listed | 2011-08-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/VIVS (~200 tokens, structured JSON with cryptographic provenance)